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ABSTRACT 
The species of lichen genus Usnea are well known for their worldwide distribution and 
medicinal properties due to presence of usnic acid. The genus is represented by more than 300 
species in the world out of which 57 species are reported from India. In India, the species of 
Usnea grows profusely in higher altitudes of Western Ghats and Himalayan regions. 20 different 
secondary metabolites are known from Indian Usnea species which have potential biological 
and physiological significance. Salazinic acid, stictic acid, norstictic acid and barbatic acid are 
the most dominant secondary metabolites along with usnic acid. Apart from the natural thalli the 
cultivated mycobiont of Usnea species also produced many of these compounds in culture 
conditions. The secondary compounds present in Usnea species are significant source of natural 
products for commercial uses. 
Key words: 
Usnic acid, mycobiont, natural 
products, secondary 
metabolites, species  
1) INTRODUCTION 
Lichens are dual organism known to produce variety of 
secondary metabolites that act as defence molecules against 
physical stress and biological attacks during their slow growth 
in nature [1] and involved in maintaining symbiotic 
equilibrium [2, 3]. Being a symbiotic organism, the secondary 
metabolites produced by lichens are unique with respect to 
those of higher plants. The secondary metabolites in lichens 
are produced by mycobiont [4], that accumulate on 
extracellular surface of fungal hyphae.  
Lichens have evolved metabolic pathways to synthesize 
secondary metabolites, mainly Acetyl-polymalonate pathway 
(APP), Shikimic acid pathway (SAP) and Mevalonic acid 
pathway (MAP). Most of the lichen compounds are phenolic 
compounds that come under orcinol/β-orcinol derivatives, 
dibenzofuranes, usnic acid, depsides (e.g. barbatic acid) & 
depsidones (e.g. salazinic acid). Due to the presence of useful 
metabolic compounds, lichens are in use for medicines, 
perfumes, dyes, cosmetics and as food from the ancient times. 
Many lichen secondary metabolites exhibit cytotoxic, 
antibiotic and antiviral properties and reported as potential 
source of pharmaceutically useful chemicals [5]. The species 
of lichen genus Usnea are most common among the different 
lichen groups used for mankind. 
Lichen genus Usnea is globally distributed with more than 300 
species [6]. In India, 57 species of Usnea are known which 
grow luxuriantly in higher regions of Western Ghats and 
Himalaya. The species of Usnea are known to be used in 
traditional medicines, in dyeing and in spices in various parts 
of the country. U. longissima Ach. has been widely used as 
expectorant, as a wound dressing and in the treatment of ulcers 
The ‘Baiga’, a primitive tribe of Madhya Pradesh used this 
species along with other ingredients for treating bone fracture 
[7]. In Unani literature the medicinal use of Usnea spp. are 
mentioned as astringent, antidote, analgesic, cardiotonic, 
resolvent and stomachic [8].  
Since synthetic drugs cause numerous side effects and 
pathogenic micro-organisms develop antibiotic resistance, the 
natural compounds present in Usnea spp., are of great interest.  
In recent years, Malhotra et al. [9] evaluated the bioactivity of 
various extracts of Usnea species and recorded their role in 
discovery of new drugs. Santiago et al. [10] and Sultana & 
Afolayan [11] studied the antitumor activity, antioxidant 
activity and antimicrobial activity of Usnea spp., against 
various plants and animal pathogens.  Rowe et al. [12] and 
Cocchietto et al., [13] studied the wide-spectrum antibiotic 
properties of Usnea spp. Singh et al. [14] reported that novel 
herbo-metallic preparation (nanoparticles) using extracts of U. 
longissima can inhibit bacterial quorum sensing. The isolated 
usnic acid has also been commercialized and is widely used as 
constituent of pharmaceutical preparations like herbal 
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medicines and cosmetics. Apart from usnic acid the Usnea 
species also produced a number of beneficial bioactive 
secondary metabolites which are not so far identified, isolated 
and characterized.  
The present study is aimed to list all the potent and useful 
secondary metabolites other than usnic acid, present in the 
Indian lichen species of Usnea and their biological activity so 
far known. 
2) MATERIALS AND METHODS 
More than 1500 specimens of lichen genus Usnea housed in 
herbarium of CSIR ̶ National Botanical Research Institute , 
Lucknow (LWG) were studied. The morphological and 
anatomical characters of species were examined using Leica 
S8APO stereo zoom microscope and Leica DM 500 micro-
system. The species were segregated using relevant keys and 
monographs [15, 16, 17]. The chemistry of the species was 
carried out using micro-crystallography and Thin Layer 
Chromatography (TLC) in solvent system A (180 ml toluene: 
60 ml 1,4 dioxane: 8 ml acetic acid) and in solvent system C 
(85 ml Toluene: 15 ml acetic acid) following Orange et al. 
[18]. 
3) RESULTS AND DISCUSSION 
The Indian species of lichen genus Usnea contain many 
biologically active secondary metabolites out of which only 21 
compounds have been isolated and identified till now (Table 
1). Out of 57 Usnea species reported from the country, 12 
species have more than one chemotypes. U. longissima, has 
maximum number of chemotypes as seven, followed by U. 
dasaea Stirt. and U. subfloridana Stirt which have five and 
four chemotypes respectively. Usnic acid, the most common 
secondary metabolite exhibits its presence in all the species of 
genus Usnea. The ecological function attributed to usnic acid 
is screening of excess light [19] as a result, species of Usnea 
growing on high altitudes could be potential source of high 
concentration of usnic acid. Apart from usnic acid, barbatic 
acid; norstictic acid; salazinic acid and stictic acids were the 
other commonly occurring lichen secondary metabolites in 
Indian Usnea species (Figure 1).  
Alectorialic acid, barbatolic acid, ceparatic acid, cryptostictic 
acid, evernic acid, hypoconstictic acid, menegazziaic acid, 
protolichesterinic acid and thamnolic acid were among the 
rarely occurring lichen substances in Indian Usnea species. 
There were 14 species which contain unidentified spots of 
secondary metabolites. These unidentified spots of lichen 
substances in Usnea can be identified using advanced 
analytical tools in near future.  
The secondary metabolites present in Indian Usnea species are 
derived from Acetate-Polymalonate Pathway (APP). These 
compounds can be broadly divided into two categories, i.e. 
aromatic products arising from inter-molecular estrification or 
oxidative coupling of orcinol/β-orcinol units and higher 
aliphatic acids. All the major secondary metabolites in Usnea 
belongs to aromatic products formed from β-orcinol units 
while ceparatic acid and protolichesterinic acid belong to 
higher aliphatic acids. 
The chemical structures and useful biological activities of 
secondary metabolites present in Indian Usnea species have 
been documented in various research reports (Table 2). The 
bioactivity of lichen substances ranges from antimicrobial, 
antiviral, antitumor, antioxidant to analgesic, antipyretic and 
cardiovascular protective activities. The number of lichen 
secondary metabolites with specific biological activities is 
given in figure 2.  
Majority of lichen substances present in Indian Usnea species 
have antimicrobial properties against plants and animal 
pathogens indicating that Indian Usnea species can be used as 
potential source of pharmaceutical medicines, herbal 
pesticides and microbicides. 
Some lichen substances are antitumor agent while others are 
antioxidant in nature. Only few lichen substances of Indian 
Usnea species are reported to be analgesic, antipyretic and 
cardiovascular protective activities. 
 
4) CONCLUSION 
According to Culberson et al. [37] and Stocker-Worgotter et 
al. [38], the chemical variation in lichens seems to be 
genetically determined but the induction of biosynthetic 
pathways for production of secondary metabolites is also 
influenced by physiological and environmental factors. The 
unique micro-climatic conditions prevailing in Indian 
subcontinent makes it suitable habitat for chemically diverse 
species of lichens, like that of Usnea. The variable abiotic 
environmental factors of different geographic regions of the 
country influence the production of lichen substances in 
Usnea species resulting in high degree of chemotypes 
formation.  
The chemical variability in Indian Usnea species can serve as 
source of valuable bio-products and are potential source of 
bio-prospection. 
Acknowledgement 
Authors are thankful to the Director, CSIR-National Botanical 
Research Institute, Lucknow for providing necessary 
laboratory facilities (OLP-083). One of the author (PS), 




1) Crittenden, P.D. and Porter, N. 1991. Lichen-forming 
fungi: potential sources of novel metabolites. Tibtech, 9, 
409. 
2) Muggia, L., Schmitt, I. and Grube, M. 2009. Lichens as 
treasure chest of natural products. Sim News, 59(3), 85-
97. 
3) Huneck, S. 2001. New results on the chemistry of lichen 
substances. Fortschr Chem Org Naturst, 81,1-276. 
4) Elix, J.A. 1996: Biochemistry and secondary metabolites. 
(In Nash, T.H. III (eds.), Lichen biology (pp. 155–180). 
London: Cambridge University Press. 
5) Molnar, K. and Farkas, E. 2010. Current results on 
biological activities of lichen secondary metabolites: a 
review. Zeitschrift für Naturforschung, 65C, 157–173.  
6) Ohmura, Y. 2012. A synopsis of the lichen genus Usnea 
(Parmeliaceae, Ascomycota) in Taiwan. Mem. Natl. Mus. 
Nat. Sci., Tokyo, 48, 91-137. 
7) Brij, L. 1988. Traditional remedies for bone-fracture 




8) Rauf, A., Latif, A., Rehman, S. & Afaq, S.H. 2011. In-
vitro antibacterial screening of extracts of Usnea 
longissima lichen. International Journal of Applied 
Biology and Pharmaceutical Technology, 2(2), 14-18. 
9) Malhotra, S., Subban, R. & Singh, A. 2008. Lichens- Role 
in traditional medicine and drug discovery. The 
International Journal of Alternative Medicine, 5(2). 
Retrieved Jan 5, 2015, from  
https://ispub.com/IJAM/5/2/4012. 
10) Santiago, K.A.A., Sangvichien, E., Boonpragop, K. & 
dela Cruz, T.E.E. 2013. Secondary metabolite profiling 
and antibacterial activities of different species of Usnea 
collected in Northern Philippines. Mycosphere, 4(2), 267-
280. 
11) Sultana, N. & Afolayanb, A.J. 2011. A new depsidone 
and antibacterial activities of compounds from Usnea 
undulata Stirton. Journal of Asian Natural Products 
Research, 13 (12),1158–1164. 
12) Rowe, J.G., Garcia Gimenez, M.D. & Rodriguez, M.T. 
1999. Some lichen products have antimicrobial activity. 
Zeitschrift für Naturforschung, 54(7-8), 605-9. 
13) Cocchietto, M., Skert, N., Nimis, P.L. & Sava, G. 2002. A 
review on usnic acid, an interesting natural compound. 
Naturwissenschaften, 89(4), 137-46. 
14) Singh, B.N., Prateeksha, Pandey, G., Jadaun, V., Singh, 
S., Bajpai, R., Nayaka, S., Naqvi, A.H., Rawat, A.K.S., 
Upreti, D.K., & Singh, B.R. 2015. Development and 
characterization of a novel Swarna-based herbo-metallic 
colloidal nano-formulation-inhibitor of Streptococcus 
mutans quorum sensing. RCS Adv., 5, 5809-5822. 
15) Awasthi, G. 1986. Lichen genus Usnea in India. J. Hattori 
Bot. Lab., 61, 333-421. 
16) Awasthi, D.D. 2007. A Compendium of the Macrolichens 
from India, Nepal and Sri Lanka. Dehra Dun: Bishen 
Singh Mahendra Pal Singh. 
17) Ohmura, Y. 2001. Taxonomic study of the genus Usnea 
(Lichenized ascomycetes) in Japan and Taiwan. J. Hattori 
Bot. Lab., 90, 1-96. 
18) Orange, A., James, P.W., & White, F.J. 2001. 
Microchemical methods for identification of lichens. 
London: British Lichen Society. 
19) Rundel, P.W. 1978. Ecological relationships of Desert 
Fog zone lichens. The Bryologist, 81(2), 277-293. 
20) Omarsdottir, S., Óladóttir, A.K., Árnadóttir, T., & 
Ingólfsdóttir, K. 2006. Antiviral compounds from 




21) Martins, M.C.B., Gonçalves de Lima, M.J., Pereira Silva, 
F., Azevedo-Ximenes,
  
E., da Silva, N.H. & Pereira, E.C. 
2010. Cladia aggregata (lichen) from Brazilian northeast: 
chemical characterization and antimicrobial activity. 
Braz. arch. biol. Technol, 53 (1), 115-122.  
22) Kumar, S. & Müller, K. 1999 a. Depsides as non-redox 
inhibitors of leukotriene B4 biosynthesis and HaCaT cell 
growth. 1. Novel analogues of barbatic and diffractaic 
acid. Eur. J. Med. Chem, 34, 1035−1042. 
23) Cobanoglu, G., Sesal, C., Aydin, Y., Ozeren Morgan, M., 
Severoglu, Z. 2006. The antimicrobial and the antifungal 
effects of some lichens with a potential medical and 
economic use in Turkey. Proceedings of the 4
th
 
International Congress of Ethnobotany (ICEB 2005), pp. 
143-146. 
24) Ravaglia, L.M., Goncalves, K., Mitsuko Oyama, N., 
Coelho, R.G., Spielmann, A.A. & Honda, N.K. 2014. In-
vitro radical scavenging activity, toxicity against A. 
Salina, and NMR profiles of extracts of lichens collected 
from Brazil and Antarctica. Retrieved Oct. 14, 2014, from 
http://dx.doi.org/10.5935/0100-4042.20140159. 
25) Shrestha, G., Atif, M., El-Naggar, Larry L. St. C. & Kim, 
L. O’Neill. 2014. Anticancer activities of selected species 
of North Americal lichen extracts. Phytotherapy 
Research. Retrieved Oct. 14, 2014, from 
http://onlinelibrary.wiley.com/doi/10.1002/ptr.5233/abstra
ct. 
26) Kumar, S. & Müller, K. 1999 b. Lichen metabolites. 
Antiproliferative and cytotoxic activity of gyrophoric, 
usnic, and diffractic acid on human keratinocyte growth. J 
Nat Prod, 62, 821–823. 
27) Halama, P. & van Haluwin, C. 2004. Antifungal activity 
of lichen extracts and lichenic acids. Bio Control, 49, 95-
107. 
28) Manojlovic, N., Gritsanapan, W., Milosev, M. & 
Manojlovic, I. 2007. Antimicrobial activity of some 




29) Rankovic, B., Misic, M. & Sukdolak, S. 2008. The 
antimicrobial activity of substances derived from lichens 
Physcia aipolia, Umbilicaria polyphylla, Parmelia 
caperata and Hypogymnia physodes. World Journal of 
Microbiology and Biotechnology, 24(7), 1239 –1242. 
30) Kwabena, X., Akobay, Egozeko L., Ardaboo, J., & 
Owechee, G.N. 2013. Hypoconstictic acid inhibits the 
growth of murine malignant central nervous system 
blastoma cells in-vitro. J. Med. Arom. Plants. Retrieved 
14, Oct, 2014, from 
http://scicomm.scimagdev.org/data/journals/277/6/Galley
%20proof%20IJMAP-2013-237.pdf.   
31) Sasidhraran, N.K., Sreekala, S.R., Lakshmanan, R., Jacob, 
J., Nair Saraswathy A., Nambisan, B. 2014. 
Protolichesterinic acid: A prominent broad spectrum 
antimicrobial compound from the lichen Usnea 
albopunctata. International Journal of Antibiotics. 
Retrieved Oct, 15, 2014, from http:// 
dx.doi.org/10.1155/2014/302182. 
32) Hirayama, T., Fujikawa, F., Kasahara, T., Otsuka, M., 
Nishida, N. & Mizuno, D. 1980. Anti-tumor activities of 
some lichen products and their degradation products. 
Yakugaku Zasshi,  100, 755–759. 
33) Behera, B.C., Verma, N., Sonone, A. & Makhija, U. 
2009. Optimization of culture conditions for lichen Usnea 
ghattensis G. Awasthi to increase biomass and antioxidant 
metabolite production. Food Technol. Biotecnol, 47(1), 7-
12. 
34) Amo De Paz, G., Raggio, J., Gómez-Serranillos, M.P., 
Palomino, O.M., González-Burgos, E., Carretero, M.E., 
Crespo, A. 2010: HPLC isolation of antioxidant 
47 
 
constituents from Xanthoparmelia spp. Journal of 
Pharmaceutical and Biomedical Analysis, 53, 165–171. 
35) Pejin, B., Iodice, C., Bogdanovic, G., Kojic´, V., & 
Tesˇevic, V. 2013. Stictic acid inhibits cell growth of 
human colon adenocarcinoma HT-29 cells. Arabian 
Journal of Chemistry. Retrieved Oct. 14, 2014, from 
http://dx.doi.org/10.1016/j.arabjc.2013.03.003. 
36) Mayer, M., O’Neill, M.A., Murray, K.E., Santosh-
Magalhaes, N.S., Carneiro-Leao, A.M.A., Thompson, 
A.M. & Appleyard, V.C.L., 2005. Usnic acid: a non-
genotoxic compound with anti-cancer properties. 
Anticancer Drugs, 16(8), 805-809.  
37) Culberson, C.F., Culberson, W.L. & Johnson, A. 1992. 
Characteristic lichen products in cultures of chemotypes 
of the Ramalina siliquosa complex. Mycologia, 84, 705–
714.  
38) Stocker-Worgotter, E., Elix, J.A. & Grube, M. 2004. 
Secondary chemistry of lichen-forming fungi: 
chemosyndromic variation and DNA analysis of cultures 
and chemotypes in the Ramalina. Bryologist, 107(2), 152-
162. 
 
Figure 1. Graph showing number of lichen secondary metabolites present in various Indian species of Usnea. 
 
 
Fig. 2. Graph showing the number of lichen secondary metabolites showing different biological activities. 
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Table 1. The secondary metabolites present in Indian Usnea species. Ale= Alectorialic acid, Bar= Barbatic acid, Bat= Barbatolic acid, Cap= Caperatic acid, Con= Constictic acid, Cry= 
Cryptostictic acid, Dif= Differactaic acid, Evr= Evernic acid, Fum= Fumaroprotocetraric acid, Gal= Galbinic acid,  Hyp= Hypoconstictic acid, Men= Menegazziaic acid, Nor= 
Norstictic acid, Pro= Protocetraric acid, Prl= Protolichesterinic acid, Pso= Psoromic acid, Sal= Salazinic acid, Sqa= Squamatic acid, Stc= Stictic acid, Thm= Thamnolic acid, Usn= 
Usnic acid, Und= undetermined spots. 
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